Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading InspireMD Inc chart...

About the Company

inspiremd, inc. is a company based out of 800 boylston street suite 16041, boston, massachusetts, united states.

CEO

Marvin Slosman

Exchange

NASDAQ

Website

http://www.inspiremd.com/

$10M

Total Revenue

56

Employees

$51M

Market Capitalization

-1.72

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NSPR News

InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript

21d ago, source: Yahoo Finance

InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.2. InspireMD, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS

1mon ago, source: Zacks.com on MSN

InspireMD, Inc. NSPR recently announced its receipt of CE Mark recertification under the European Union’s (EU) new Medical ...

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

22d ago, source: Business Insider

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced financial and ...

InspireMD (NSPR) Earnings Dates & Reports

22d ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

VIVE Viveve Medical, Inc.

1d ago, source: Seeking Alpha

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function ...

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

22d ago, source: Stockhouse

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced financial and ...

InspireMD Inc. (NSPR) Q4 2023 Earnings Call Transcript

22d ago, source: Seeking Alpha

Greetings. Welcome to InspireMD Fourth Quarter and Full Year 2023 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to ...

InspireMD, Inc.: InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

22d ago, source: Finanznachrichten

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced financial and ...

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

22d ago, source: Yahoo Finance

TEL AVIV, Israel and MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...